CD8A and viral infectious disease: Recombinant IL-2 could enhance T cell survival (49), reverse T cell anergy, and maintain virus-specific CD8+ T cell numbers and function during persistent viral infection (26), such as HIV (50, 51), simian immunodeficiency virus (SIV) (52, 53), and LCMV (49).